Target intelligence / Profile preview

Absent in melanoma 2 inflammasome (AIM2 inflammasome)

Target
AIM2 inflammasome
Molecular classification
Sensor protein (e.g., AIM2, IFI16), Multiprotein complex, Innate immune receptor, Intracellular pattern recognition receptor (PRR)
01

Overview

DNA sensor-dependent inflammasomes are innate immune complexes that form in response to cytosolic or nuclear DNA, typically during infection, cell damage, or stress. The best-characterized example is the AIM2 inflammasome, which is activated by double-stranded DNA (dsDNA) of at least 70–200 base pairs in length. AIM2 contains a HIN200 domain that binds DNA in a sequence-independent manner, and a pyrin domain that interacts with the adaptor ASC, which in turn recruits caspase-1, leading to maturation of inflammatory cytokines (IL-1β, IL-18) and induction of pyroptosis. IFI16 is another DNA sensor with weaker DNA affinity, but can assemble similar complexes and is particularly important for nuclear DNA sensing. NLRP3 may respond to DNA derivatives under specific conditions. These inflammasomes play essential roles in host defense, inflammatory and autoimmune diseases, cancer, and regulation of homeostasis. However, activation by self-DNA can promote pathological inflammation and autoimmunity. There are currently no approved drugs that directly target AIM2/IFI16 inflammasomes, though targeting the pathway is an area of therapeutic research.

Other names
AIM2 inflammasomeIFI16 inflammasomeNLRP3 inflammasomecytosolic DNA sensor inflammasomeDNA-induced inflammasome
02

Mechanism of action

Inhibition of inflammasome assembly, inhibition of caspase-1 activation, inhibition of IL-1β and IL-18 secretion, blockade of pyroptosis, and modulation of pattern recognition receptor signaling.

03

Biological functions

Immune responseInflammationPyroptosis (inflammatory cell death)Secretion of interleukin 1β (IL-1β) and interleukin 18 (IL-18)Host defense against bacteria and virusesRegulation of gut microbiota
04

Disease associations

InflammationAutoimmune diseaseInfectious diseaseCancerColitisNonalcoholic steatohepatitis (NASH)Neurodegeneration (possible)
05

Safety considerations

Excessive immune suppression leading to infection riskDisruption of gut microbiota and mucosal immunityPotential for autoimmune exacerbation if not properly targetedOff-target effects due to lack of complete specificity
06

Biomarkers

Caspase-1 activityIL-1β and IL-18 (serum or tissue levels)Gasdermin D cleavageASC speck formation

Beyond the preview

Go deeper on Absent in melanoma 2 inflammasome (AIM2 inflammasome).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Absent in melanoma 2 inflammasome (AIM2 inflammasome).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call